openPR Logo
Press release

Global CDMO Market to reach USD 233.71 billion in 2024 at a CAGR of 7.25% by 2032, Evaluates DelveInsight

10-13-2025 09:04 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global CDMO Market to reach USD 233.71 billion in 2024 at a CAGR

According to DelveInsight's analysis, The Contract Development and Manufacturing Organization (CDMO) market is witnessing robust growth, fueled by the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes, which has boosted demand for innovative therapies. Additionally, the growing need for biologics and small-molecule drugs, given their efficacy in managing complex conditions, is driving the expansion of outsourced drug development and manufacturing services.

DelveInsight's "Contract Development Manufacturing Organization Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Contract Development Manufacturing Organization companies actively working in the market.

To know more about why North America is leading the market growth in the Contract Development Manufacturing Organization market, get a snapshot of the report Contract Development Manufacturing Organization Market Trends
https://www.delveinsight.com/sample-request/contract-development-manufacturing-organization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contract Development Manufacturing Organization Overview
A CDMO (Contract Development and Manufacturing Organization) is a company that provides comprehensive services to pharmaceutical and biotechnology firms, covering everything from drug development and formulation to commercial-scale manufacturing.
CDMOs help streamline the drug development process by offering expertise, advanced facilities, and regulatory compliance, allowing pharma companies to reduce costs, save time, and focus on core activities like research and marketing. They play a vital role in bringing new drugs, biologics, and therapies to market efficiently and safely.

DelveInsight Analysis: The global CDMO market size was estimated at USD 233.71 billion in 2024 and is projected to expand at a CAGR of 7.25% between 2025 and 2032, reaching approximately USD 407.09 billion by 2032.

Contract Development Manufacturing Organization Market Insights
Geographically, North America is expected to hold the largest share of the CDMO market in 2024. This leadership is driven by several factors, including the rising prevalence of chronic diseases such as cancer and tuberculosis. Additionally, the benefits offered by CDMOs-such as streamlining drug development and manufacturing processes-are encouraging pharmaceutical and biotechnology companies to outsource these services to reduce costs, enhance efficiency, and accelerate time-to-market, further supporting market growth throughout the forecast period from 2025 to 2032.

To read more about the latest highlights related to Contract Development Manufacturing Organization, get a snapshot of the key highlights entailed in the Contract Development Manufacturing Organization
https://www.delveinsight.com/report-store/contract-development-manufacturing-organization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Contract Development Manufacturing Organization Market Report
• In May 2025, Lupin Manufacturing Solutions (LMS) announced a strategic realignment of its core assets and long-term vision to leverage emerging opportunities in the CDMO sector. By investing in innovative therapeutic platforms and utilizing India's strong API ecosystem, LMS aims to strengthen its capabilities and drive sustainable growth in the global contract development and manufacturing market.
• In May 2025, VGXI, Inc., a CDMO focused on plasmid DNA for gene therapies and vaccines, successfully passed a US FDA inspection at its GMP facility, resulting in the approval of a client's Biologics License Application (BLA). This achievement underscores VGXI's dedication to quality and regulatory compliance.
• In May 2025, Tivic Health® Systems, Inc. announced a definitive agreement with Scorpius BioManufacturing to carry out GMP manufacturing validation of EntolimodTM, its lead TLR5 candidate for Acute Radiation Syndrome (ARS), in preparation for an FDA BLA submission.
• In March 2025, Ayrmid Pharma Ltd. and RoslinCT revealed plans to establish a strategic partnership for the manufacturing of Omisirge, a cell therapy for treating hematologic malignancies, which is commercialized in the U.S. by Ayrmid's subsidiary, Gamida Cell Inc.
• In February 2022, China-based CDMO Asymchem Inc. intends to acquire Snapdragon Chemistry, a U.S.-based firm specializing in continuous manufacturing and early-stage chemical process development, for a total of USD 57.94 million. The deal is aimed at expanding the Chinese CDMO's presence and operations in the U.S. market.
• In February 2022, MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, completed the acquisition of Exelead for around USD 780 million in cash. This acquisition is expected to strengthen the Life Sciences division's capabilities, positioning it as a leading CDMO within the mRNA value chain.
• Thus, owing to such developments in the market, rapid growth will be observed in the Contract Development Manufacturing Organization market during the forecast period

Key Players in the Contract Development Manufacturing Organization Market
Some of the key market players operating in the Contract Development Manufacturing Organization market include- Thermo Fisher Scientific Inc., Catalent Inc., The Lubrizol Corporation, Recipharm (EQT), Cambrex Corporation, Merck & Co. Inc., AGC Biologics, Nerpharma S.r.l, Pfizer Inc, EMERGENT, Onyx Scientific Limited, Lonza, Siegfried Holding AG, CordenPharma International, FUJIFILM Diosynth Biotechnologies, Samsung Biologics, Delpharm, Center for Breakthrough Medicines, WuXi Biologics, Laboratoire Elaiapharm, and others.

Which MedTech key players in the Contract Development Manufacturing Organization market are set to emerge as the trendsetter explore @ Key Contract Development Manufacturing Organization Companies
https://www.delveinsight.com/sample-request/contract-development-manufacturing-organization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Contract Development Manufacturing Organization Market Landscape
Moreover, the growing demand for biologics and small-molecule drugs is driving significant growth in the CDMO market, as pharmaceutical and biotechnology companies increasingly rely on specialized partners to handle these complex, resource-intensive processes. Biologics-including monoclonal antibodies, vaccines, and recombinant proteins-represent some of the fastest-growing segments in the industry. Their development and manufacturing require advanced infrastructure, strict quality controls, and sophisticated technologies such as cell culture, fermentation, and purification.
Collectively, these factors are expected to support the expansion of the global CDMO market throughout the forecast period from 2025 to 2032.

Scope of the Contract Development Manufacturing Organization Market Report
• Coverage: Global
• Study Period: 2022-2032
• Contract Development Manufacturing Organization Market Segmentation By Drug Type: Small Molecules and Biologics
• Contract Development Manufacturing Organization Market Segmentation By Service Type: API and Finished Drug Products), Forms (Solids and Liquids), Manufacturing, (Clinical Manufacturing and Commercial Manufacturing
• Contract Development Manufacturing Organization Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Contract Development Manufacturing Organization Companies: Thermo Fisher Scientific Inc., Catalent Inc., The Lubrizol Corporation, Recipharm (EQT), Cambrex Corporation, Merck & Co. Inc., AGC Biologics, Nerpharma S.r.l, Pfizer Inc, EMERGENT, Onyx Scientific Limited, Lonza, Siegfried Holding AG, CordenPharma International, FUJIFILM Diosynth Biotechnologies, Samsung Biologics, Delpharm, Center for Breakthrough Medicines, WuXi Biologics, Laboratoire Elaiapharm, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Contract Development Manufacturing Organization market will grow by 2032? Click to get a snapshot of the Contract Development Manufacturing Organization Market Analysis
https://www.delveinsight.com/sample-request/contract-development-manufacturing-organization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global CDMO Market to reach USD 233.71 billion in 2024 at a CAGR of 7.25% by 2032, Evaluates DelveInsight here

News-ID: 4221595 • Views:

More Releases from DelveInsight Business Research

Global Occlusion Devices Market to grow at a CAGR of 6.31% by 2030, Evaluates DelveInsight
Global Occlusion Devices Market to grow at a CAGR of 6.31% by 2030, Evaluates De …
According to DelveInsight's analysis, The demand for occlusion devices is largely driven by the growing number of patients affected by various chronic conditions. Additionally, rapid technological advancements, rising preference for minimally invasive surgeries (MIS), favorable reimbursement policies for MIS, and an expanding geriatric population are key factors contributing to the overall growth of the occlusion devices market between 2024 and 2030. DelveInsight's "Occlusion Devices Market Insights, Competitive Landscape and Market Forecast-2030"
Hypoxia Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight
Hypoxia Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation b …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hypoxia pipeline constitutes key companies continuously working towards developing Hypoxia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Hypoxia Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hypoxia Market. The Hypoxia Pipeline report embraces in-depth commercial and
Hypoglycemia Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsigh
Hypoglycemia Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hypoglycemia pipeline constitutes 10+ key companies continuously working towards developing 12+ Hypoglycemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Hypoglycemia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
Urinalysis Market to Reach USD 9.02 Billion by 2032, Growing at a 9.1% CAGR, Says DelveInsight
Urinalysis Market to Reach USD 9.02 Billion by 2032, Growing at a 9.1% CAGR, Say …
According to DelveInsight's assessment, the rising prevalence of urinary disorders such as urinary tract infections (UTIs), chronic kidney disease, and hospital-acquired infections is driving strong demand for urinalysis testing, as early diagnosis is essential for timely and effective treatment. Growing public awareness of health and wellness, along with government-led and private healthcare initiatives, is encouraging individuals to opt for routine diagnostic screenings. In parallel, educational efforts by healthcare providers continue

All 5 Releases


More Releases for Manufacturing

Manufacturing the Future: Exploring the In-Space Manufacturing Market
Rapid improvements in space technology have created new opportunities for in-space production, transforming the space sector. The in-space manufacturing sector is expanding rapidly as space agencies and private companies investigate ways to manufacture products and structures in space. According to MarketsandMarkets' thorough market research analysis, the worldwide in-space manufacturing market is predicted to expand significantly in the next years. In this blog article, we will evaluate the recent trends and
Global Miscellaneous Market by Types (Gasket, Packing, and Sealing Device Manufa …
The global Miscellaneous market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period. Global Miscellaneous Market overview Miscellaneous Market research report offers great insights into the market and consumer data and their interpretation through various figures and graphs. Miscellaneous markets have experienced significant growth in recent years. The main reason for this is the increasing
Smart Factory Transforming from “Manufacturing” to “Intelligent Manufactur …
The concept of “Industry 4.0” was officially announced by the German government in 2013 at the Hannover Messe. Since then, its influence has taken the world by storm. From steam mechanization to power automation to data informatization, the Industry 4.0, driven by “intelligentization”, will completely subvert the expectations, changing perceptions of productivity and production relations in the traditional manufacturing industry by way of qualitative change – an immortal monument, perhaps,
Additive & Conventional Manufacturing – Hybrid Manufacturing Techniques From C …
Croft Filters, based in Warrington, England, have been supplying custom filtration and separation solutions for over 31 years. Over this time, Croft has developed a reputation for their quality, bespoke service through manufacturing a variety of products for specific requirements. These products have included Filtration Cones, Baskets & Screens, Disc Filters and Filtration Housings amongst others, and they are made with Wire Mesh, Wedge Wire and Perforated Plate, depending on
Digital Meter Market 2017 - Al-Jon Manufacturing, Environmental Manufacturing, H …
The Global Digital Meter Market 2017 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Digital Meter industry. First, "Global Digital Meter Industry 2017" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Digital Meter industry chain structure. Major Companies Covered in this report:- Al-Jon Manufacturing Heitman Laboratories Kws Manufacturing Company Kmb Systems Obvius Holdingd Llc Lubecorp Manufacturing Quadlogic
Competitive Segmentation of Global Mixed-mode Manufacturing Market 2016 Industry …
The market research report titled Mixed-mode Manufacturing Market Research Report 2016 provides a detailed overview of the global Mixed-mode Manufacturing market, in terms of crucial market factors such as the demand drivers, challenges, market segments, key companies, and the recent market trends. The quantitative and the qualitative information presented in this research study is based on primary and secondary sources of information. Moreover, much of the information contained in this